Azenta ( (AZTA) ) just unveiled an update.
Azenta, Inc. has appointed Lawrence Lin as its new CFO, succeeding Herman Cueto, who will stay on as an advisor to ensure a smooth transition. The company reported a 4% revenue growth for FY’24 and expects organic revenue growth of 3% to 5% in FY’25. Azenta is also planning to sell B Medical Systems to streamline its portfolio, aiming for improved profitability. The company’s strong performance in Sample Management Solutions and Multiomics, along with strategic moves, highlights its focus on long-term shareholder value.
See more data about AZTA stock on TipRanks’ Stock Analysis page.
